Joburg woman finishes epic N1 walk to Cape Town for husband's rare disease 10 days early
Nicole Liedemann-Telukram completed her 1 400km walk from Johannesburg to Cape Town 10 days ahead of schedule, raising awareness and funds for her husband Shaun's rare condition, Dercum's disease.
Supported throughout the journey by her best friend, Paballo, in a safety vehicle and her trusty boerboel, Zaza, Nicole described the journey as physically and emotionally transformative, highlighting the mental endurance required and the generosity of South Africans along the way.
The campaign has raised R15 000 so far, and Nicole remains committed to fighting for rare disease research and funding, saying, 'This is just the start.'
Nicole Liedemann-Telukram has completed her 1 400km walk from Johannesburg to Cape Town, 10 days ahead of schedule.
Just over a month ago, Nicole decided to embark on a journey along the N1 to raise awareness and funds for her husband Shaun Telukram's rare disease, called Dercum's disease.
She documented the trip on TikTok and directed followers to her fundraising platforms.
- See Nicole's BackaBuddy page
More than a month after starting the walk, she arrived in sunny Cape Town to take a photo at the famous V&A Waterfront sign.
Her journey was not without difficulties. A pulled hamstring just after Lainsburg and the physical demands of walking the Huguenot Tunnel tested her endurance. One of the most physically taxing parts of her journey was near Colesberg when she battled blisters and the flu.
'My body felt like it was giving up on me,' Nicole told News24 in Cape Town.
'When you are walking, it's only yourself and your thoughts. I don't walk with earphones in; it's just myself and the road. Your mind gets to you, where you feel self-doubt, but you have to pull yourself towards yourself and remind yourself the reason why you are doing it.'
While the first leg of the journey began with excitement, the second half became more difficult.
'It's not just about Dercum's, it's about so many things,' she said.
Nicole expressed deep gratitude for the support of her best friend, Paballo, who accompanied her by car for the entire journey for safety and her trusty boerboel, Zaza.
'Paddy, my sister, my best friend, motivator, Swiss Army knife, master of all... I could not be more grateful. I don't think there are enough words to describe how blessed I was to have had her on this journey. Yes, I was walking, but I could not have done it without her.'
Supplied/Neo Paballo-Mahao
Because the pair remained vigilant, they generally felt safe on their journey. One hair-raising moment came in Paarl, where they heard that a body had been found nearby. This did not deter them: 'There was a task that needed to be completed, a personal task, a mental task, an emotional task, a physical task. And yes, we completed it. I'm still in awe.'
Kind South Africans and the plight goes on
Nicole arrived in Cape Town last week with a deep sense of fulfilment.
'I sat there in silence with a big smile on my face. We did it. I actually did it. When you do something out of your comfort zone and succeed, it takes you back a little. I was filled with emotion, excitement and fulfilment.'
READ | Joburg woman halfway through N1 walk to Cape Town, beating blisters, blessed by strangers
Messages of pride and congratulations from family and friends continue to pour in.
'I hope I reached the people I needed to. The people we spoke to along the way made it all worthwhile. Mentally, I'm okay – I haven't processed everything yet, but I'm still extremely positive and optimistic.'
The campaign has so far raised around R15 000 and Nicole is determined to continue her fundraising efforts and search for sponsors, as they aim to reach R200 000. Dr Karen Herbst, one of the leading Dercum's researchers in the world, based in the US, also got in touch to amplify Nicole's efforts.
'We did not raise too much, but my plight has not stopped. I'm still continuing to raise awareness and funds. We didn't raise much at all, but it doesn't take away from the reason why I did this and why I am still going to continue to fight for a rare disease and for my husband.'
Rare disease research is underfunded. We need chemical pathologists to do the work, but we also need the funding. My mission is not complete yet.
Reflecting on the experience, Nicole said the journey was unforgettable.
'South Africa is a beautiful place. People in small towns are kind and generous. The trucking community became our cocoon of safety. We stayed at truck stops. There are so many people I want to thank. There are a lot of amazing people in this country.'
'This is just the start.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News24
18 hours ago
- News24
The Lead: Wouter Basson vs HPCSA round two, with Tammy Petersen
The Health Professions Council of South Africa (HPCSA) continues in 2025 to push for some form of historical accountability from 'Dr Death' Wouter Basson's involvement in the apartheid government's secret chemical and biological warfare programme, 'Project Coast'. But as News24's Cape Town journalist Tammy Petersen reports in this edition of The Lead, the Durbanville-based cardiologist has, at the age of 74, turned to the High Court to get the HPCSA off his back once and for all: 'Dr Basson argues in his court papers that this new bid by the HPCSA is nothing but persecution,' says Petersen. Later in the show, we learn that a former Transnet official is wanted by the police for the mistaken hit on a Vereeniging engineer whose company blew the whistle on procurement corruption. Finally, attorneys for disgraced R&B singer R Kelly claim he's in danger behind bars and argue that he should be put under house arrest. Listen on YouTube: Listen on Apple Podcasts:
News24
20 hours ago
- News24
‘Being clean is a feeling everyone deserves': Campaign uplifts Eastern Cape school toilets
The Unstoppable Together campaign has increased the percentage of functional toilets meeting health standards in Eastern Cape schools from 8% to 44% this year. Be among those who shape the future with knowledge. Uncover exclusive stories that captivate your mind and heart with our FREE 14-day subscription trial. Dive into a world of inspiration, learning, and empowerment. You can only trial once.
News24
a day ago
- News24
Motsoaledi's big HIV treatment jump: Is it true?
@GovernmentZA/X formerly Twitter Last month, the health minister said that more than half a million previously diagnosed people with HIV have been started on treatment since the end of February. But can it really be, especially since the gap to getting 95% of people diagnosed with HIV on medication has been hovering around 1-million for the past five years? Critics say they're sceptical about the minister's figures — and that the country will close the gap by December. Numbers are powerful. They can also be dangerous — if not used correctly. When the health minister said last month that 520 700 extra people previously diagnosed with HIV had been started on treatment since the end of February, the number sounded astounding. The health department's goal is to find 1.1-million people who know they have HIV, but either never started treatment, or fell out of treatment, before the end of the year. In his words, the department has reached 'more than 50% of the target' they set out to achieve by the end of the year. If that gap is closed, South Africa would have met two of the three so-called 95-95-95 goals the country signed up for as part of the United Nations plan to end Aids as a public health threat by 2030. However, knowing by exactly how much the gap is closing is tricky, because people who know they have HIV may start and stop and then restart treatment again later — sometimes several times — during the course of their care. In fact, a study from the Western Cape shows that close to half of people on medication stop at least once, and that some even pause and then restart up to three times. So, many of the 520 700 previously diagnosed people Motsoaledi says are now on medication could, at least in theory, very well be people who are counted repeatedly as they cycle in and out of treatment. But because the patient information system isn't digitally centralised — most clinics still keep track of their clients on paper, which means different facilities can't easily access one another's records — someone who stops treatment at one clinic can easily be counted as a new start at another, rather than a restart. The set of UN targets aim for 95% of people in a country with HIV to know their diagnosis, 95% of those to be on treatment and 95% of those taking medication to have such low levels of virus in their bodies that they can't infect someone through sex. 'The reason that we [were] able to reach half a million within a short space of time, was because of weekly check-in meetings with provinces, where reports that come from the ground are verified in the presence of all provincial colleagues before they are regarded as final figures for reporting,' said the minister. But simply counting better isn't the same as doing better, and critics called the reported progress 'inconceivable'. Why? Because for the last few years, the number of people with HIV who have gone on treatment has crept up very slowly, so much so that the gap to 95% has remained more or less the same for about five years. (At the moment just over 80% of people diagnosed with HIV are on treatment.)* Moreover, that was while treatment programmes had funding and US-backed money for HIV projects was in place. So now, at a time of funding shortfalls, programmes closing and the government scrambling to plug the holes, could nearly half of the number of people who need to get on treatment really have been added in just 10 weeks? We dive into the data to get a sense of what the numbers really mean. Mind the gap In 2021, South Africa was about 1.2 million people short of its 95%-treatment goal; by 2025 the shortfall will likely be 990 000. That means that the gap — that is, the difference between where the country actually is and where it wants to be when it comes to HIV treatment — has closed by about 210 000. Bhekisisa So, there's been progress, but it's been slow: in total, only about 700 000 more people are on HIV medication today than five years ago. 'Getting that last one million or so people on treatment is not simple,' says Kate Rees, public health specialist at the Anova Health Institute. Part of the reason for this, she says, is that a large proportion of the group needed to close the gap are people who have in fact been on ARVs before but have since stopped. Sometimes people miss an appointment to get a refill of their medicine because they can't afford to take time off work to go to the clinic or they might have moved to another province or district and so they don't go back to the facility where they first got their prescription, she explains. The longer the interruption lasts, the more hesitant people are to go back, says Rees, because they dread being treated poorly or getting 'kicked to the back of the queue' for having missed an appointment, with especially people like sex workers, trans folk or men who have sex with men facing judgement. Says Rees: 'The health service expects people to be very rigid with their appointments, but life just is not like that.' Slow progress To get a sense of the progress towards meeting the UN's second target in its 95-95-95 cascade, it's best to look at the difference in the total number of people on HIV treatment from year to year, says Leigh Johnson, one of the lead developers of the Thembisa model, which is used to report South Africa's official statistics to UNAids. Bhekisisa Although the number of people on medication is increasing, the number grows less and less each year. For example, in 2020, about 291 000 more people were on treatment than in 2019. By 2021, though, the number had grown only by about 225 000. Current forecasts from the model are that the total number of people on treatment will grow by only around 160 000 this year. But that's based on programmes running like they have up to now — and with recent upsets because of US funding cuts, it may be an unreasonable assumption, Johnson says. Part of the reason for the small net gain every year, is that although many people sign up for medication in a year, many also stop coming back to get their scripts refilled. Of those who drop out of treatment, some might choose to restart within a couple of months again, while others may pause their treatment for more than a year. Bhekisisa In 2023, for example, roughly 793 500 people who had been on treatment before weren't any longer, but about 728 000 who received medication were restarters, Thembisa numbers show. Bhekisisa So even though some people who stop taking their medication might not restart — or restart quickly — the total number who are on treatment still grows; it's just slow-going. This means getting a handle on how close to — or far from — the 95%-treatment mark South Africa is, is more dynamic than simple addition. Stops, starts and restarts 'There will always be people who interrupt their treatment,' says Rees. 'It's not possible to keep everyone perfectly in the system all the time — that's life.' But what's important, she says, is to make those pauses as short as possible by helping people to get back on medication quickly and easily — without judgement. Gesine Meyer-Rath agrees. She's a health economist at HE2RO, a health economics research group at the University of the Witwatersrand, and focuses on how the government can get the most bang for its buck in its HIV programme. Data in the Thembisa model shows that over the years, the number of people starting medication for the first time — in other words, those who have never been on treatment before — has shrunk, but at the same time counts of restarters have grown. Her group's analyses have shown that honing in on keeping people on HIV treatment is the best way to go — especially now that funding is shrinking — and that 'we can close the 1.1-million gap through improved retention alone'. But to plan sensibly, she explains, policymakers should know how many people are first-time starters, how many pause treatment but then restart, and how many stop and don't come back at all. 'The more detail programme planners have in the data, the better,' she says. 'The [government's] 'Close the Gap' campaign has a lot of good ideas, but having the right numbers of where the gap is that we want to close is crucial, as is keeping these numbers accurate as we progress.' This is exactly where things can become tricky in future if the holes left by the US funding cuts aren't plugged. Because of the US's aid withdrawal, about 40% of South Africa's HIV data capturers will likely have lost their jobs by September, Bhekisisa reported last month, and this means the information needed to shape where money has to be spent to make real progress in ending Aids as a public health threat over the next five years simply might not be available. Says Meyer-Rath: 'The less data we have, the more we're flying blind, which leaves space for bickering over the data that is still there.'
